1 completed. 1 Phase 3.
| Phase | Trials | Status |
|---|---|---|
| Phase 3 | 1 | Completed 1 |
Follow Diffuse Large B Cell Lymphoma (DLBCL): new trials by email Literature Review of Diffuse Large B Cell Lymphoma (DLBCL) trials Research Report on Diffuse Large B Cell Lymphoma (DLBCL)
Tick up to 5 trials to compare them side by side (eligibility, arms, endpoints, adverse events) in a Literature Matrix.
| Trial | Phase | Status | Sponsor | Enrollment | Start | Updated |
|---|---|---|---|---|---|---|
| R-CHOP Versus R-mini-CEOP in Elderly Patients(>65)With DLBCL Cyclophosphamide, Doxorubicin, Vincristine - Elderly Patients (>65 Years), Diffuse Large B Cell Lymphoma (DLBCL) | Phase 3 | Completed | Fondazione Italiana Linfomi - ETS | 226 | 2003-01-01 | 2010-06-22 |
Lymphoma, Large B-Cell, Diffuse (1)
Hemic and Lymphatic Diseases (1) · Immune System Diseases (1) · Immunoproliferative Disorders (1) · Lymphatic Diseases (1) · Lymphoma (1) · Lymphoma, B-Cell (1) · Lymphoma, Non-Hodgkin (1) · Lymphoproliferative Disorders (1) · Neoplasms (1) · Neoplasms by Histologic Type (1)
Cyclophosphamide (1) · Doxorubicin (1) · Epirubicin (1) · Granulocyte Colony-Stimulating Factor (1) · Prednisone (1) · Rituximab (1) · Vinblastine (1) · Vincristine (1)
Fondazione Italiana Linfomi - ETS (1)
Italy (1)
Francesco Merli, MD (1) · Marilena Bertini, MD (1)